0 Commentaires
0 Parts
322 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Artificial Intelligence (AI)-based Clinical Trials Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Executive Summary Artificial Intelligence (AI)-based Clinical Trials Market Market Size and Share Analysis Report Data Bridge Market Research analyses that the artificial intelligence (AI)-based clinical trials market which was USD 1.3 billion in 2021, would rocket up to USD 5.55 billion by 2029, and is expected to undergo a CAGR of 19.90% during the forecast period 2022 to 2029. In...0 Commentaires 0 Parts 366 Vue 0 Aperçu
-
Clinical Trials Management System Market Growth Trends and Forecast 2033The landscape of medical research is shifting beneath our feet. Gone are the days of overflowing filing cabinets and disjointed spreadsheets. Today, the pulse of drug development beats through digital veins, specifically via the Clinical Trials Management System market. If you are a stakeholder in the pharmaceutical, biotech, or medical device industries, understanding this ecosystem isn't...0 Commentaires 0 Parts 313 Vue 0 Aperçu
-
Decentralized Clinical Trials Market: Emerging Trends and Industry OutlookThe pharmaceutical industry has long been known for its tradition, meticulousness, and let’s be honest a fair bit of slow-moving bureaucracy. For decades, clinical trials followed a rigid "brick-and-mortar" site model. Patients traveled hours to hospitals, sat in waiting rooms, and filled out endless stacks of paper. It was a system that worked, but it wasn't exactly efficient or...0 Commentaires 0 Parts 412 Vue 0 Aperçu
-
Europe Neurology Clinical Trials Market Growth Insights 2025-2034The Europe Neurology Clinical Trials Market is witnessing steady growth as the prevalence of neurological disorders such as Alzheimer’s, Parkinson’s, multiple sclerosis, and epilepsy continues to rise. Valued at USD 1.90 billion in 2024, the market is projected to reach USD 3.55 billion by 2034, registering a CAGR of 6.5% during the forecast period....0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global Virtual Clinical Trials Market Analysis: Size, Share, Innovations, and Future OpportunitiesVirtual Clinical Trials Market: Revolutionizing Healthcare Through Digital Innovation Virtual clinical trials leverage digital technologies like telemedicine and AI platforms to conduct studies remotely, enhancing patient access and trial efficiency. This approach addresses traditional limitations by enabling decentralized participation across designs such as interventional, observational, and...0 Commentaires 0 Parts 746 Vue 0 Aperçu
-
Rising Clinical Trials Fueling the Medical Device and Diagnostics Contract Research Organization Market GrowthThe global clinical research ecosystem is undergoing a dynamic transformation driven by technological innovation, evolving regulatory requirements, and the increasing demand for efficient healthcare solutions. Contract research organizations (CROs) specializing in medical devices and diagnostics have emerged as essential partners for manufacturers by offering expertise in clinical trials,...0 Commentaires 0 Parts 166 Vue 0 Aperçu
-
Wearable Biosensors in Clinical Trials Market Companies: Growth, Share, Value, Size, and Insights"Future of Executive Summary Wearable Biosensors in Clinical Trials Market: Size and Share Dynamics Global wearable biosensors in clinical trials market size was valued at USD 384.24 million in 2024 and is projected to reach USD 885.50 million by 2032, with a CAGR of 11.00% during the forecast period of 2025 to 2032. A DBMR team of experts and professionals from a number of streams...0 Commentaires 0 Parts 597 Vue 0 Aperçu
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Are eTMF Systems Revolutionizing Clinical Trial Documentation and Compliance?Executive Summary Electronic Trial Master File (eTMF) Systems Market Size and Share Across Top Segments CAGR Value The global electronic trial master file (eTMF) systems market size was valued at USD 1.84 billion in 2024 and is expected to reach USD 4.85 billion by 2032, at a CAGR of 12.90% during the forecast period Market drivers and market...0 Commentaires 0 Parts 275 Vue 0 Aperçu
-
Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...0 Commentaires 0 Parts 135 Vue 0 Aperçu
-
Are Innovations in Treatment Improving Life for Parkinson’s Patients?Market Trends Shaping Executive Summary Parkinson’s Disease Treatment Market Size and Share CAGR Value Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period. A complete discussion...0 Commentaires 0 Parts 473 Vue 0 Aperçu
-
Are Innovative Heart Failure Drugs Changing the Outlook for Cardiovascular Care?Executive Summary Heart Failure Drugs Market Size and Share Forecast CAGR Value Data Bridge Market Research analyses that the heart failure drugs market which was USD 8,010.62 million in 2023, would rocket up to USD 24,919.55 million by 2030, and is expected to undergo a CAGR of 15.56% during the forecast period. This Heart Failure Drugs Market Research Report also conducts analysis...0 Commentaires 0 Parts 213 Vue 0 Aperçu
-
Are Personalized Cancer Vaccines the Future of Oncology Treatment?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value Data Bridge Market Research analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030. The market...0 Commentaires 0 Parts 281 Vue 0 Aperçu
-
Are Prescription Drugs Driving the Next Era of Global Healthcare Innovation?Key Drivers Impacting Executive Summary Prescription Drugs Market Size and Share CAGR Value The global prescription drugs market size was valued at USD 1,230.28 billion in 2024 and is expected to reach USD 2,451.41 billion by 2032, at a CAGR of 9.00% during the forecast period The large-scale Prescription Drugs Market report presents the best...0 Commentaires 0 Parts 215 Vue 0 Aperçu
-
Can Advances in PKU Treatment Improve Quality of Life for Patients?Global Executive Summary Phenylketonuria (PKU) Treatment Market: Size, Share, and Forecast CAGR Value Phenylketonuria (PKU) treatment market size is projected to grow at a compound annual growth rate of 10.95% over the forecast period of 2022 to 2029. The global Phenylketonuria (PKU) Treatment Market analysis report gives a careful overview of the research trends for the financial year....0 Commentaires 0 Parts 185 Vue 0 Aperçu
-
Can Innovation Accelerate the Fight Against Malaria Worldwide?Executive Summary Malaria Treatment Market Research: Share and Size Intelligence CAGR Value The expected CAGR of malaria treatment market is tend to be around 6.6% in the mentioned forecast period. The market value is USD 647.13 million in 2022, and it would grow upto USD 1079.07 million by 2030. The credible Malaria Treatment report has estimations of CAGR values, which are very...0 Commentaires 0 Parts 357 Vue 0 Aperçu
-
Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Commentaires 0 Parts 173 Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek